Mizuho maintains Ryan Specialty Holdings at Neutral, raises price target to $48 from $40

Mizuho kept Ryan Specialty Holdings at Neutral but raised its price target to $48 from $40, a 20% increase. This implies a 4% upside from the Nov 12 close of $46.15. Recent analyst targets range from $46 to $52.

Original reporting
Published Nov 13, 2026, 5:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 5:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Mizuho maintains Ryan Specialty Holdings at Neutral, raises price target to $48 from $40 — source image
Decision brief

The 30-second read

$RYANBullishLow
01

Why it matters

The only actionable new detail is the PT increase from $40 to $48 while maintaining a Neutral rating; no new company event is disclosed.

02

Market read

This is a modest sentiment tailwind for RYAN, but it is not a fundamental catalyst.

03

What to watch

Without the underlying thesis or any new Ryan Specialty data, traders may discount the PT change and focus on upcoming earnings or broader market moves.

Relevance 4/10Novelty 4/10Timing: today, as the analyst price-target update circulates

Background

The piece summarizes an analyst note from Mizuho and compares it with other recent analyst price targets.

Company-level read

Ticker impact

$RYANBullishMedium confidence
Context

Mizuho maintained Ryan Specialty at Neutral and raised its price target to $48 from $40, implying modest upside from the Nov 12 close.

Expected impact

Likely mild upward bias as traders price in the higher target, with limited follow-through unless other analysts or fundamentals move.

Evidence & confidence

The article provides only a PT change and does not cite new Ryan Specialty-specific operational or financial disclosures.

Market effects

Minimal, since this is a single-name analyst target change with no sector-wide catalyst described.

None indicated.

None indicated.

Counterpoint

The raised target may already be anticipated by the market given the recent range of analyst targets, limiting incremental impact.

Key entities

  • Ryan Specialty Holdings

    Subject of the analyst action, with Mizuho raising its price target to $48 from $40 while keeping Neutral.

Related articles

$RYANMed

Ryan Specialty Holdings Inc (RYAN) (Q3 2026) Earnings Call Highlights: Revenue Growth

Ryan Specialty Holdings (RYAN) reported Q3 2026 revenue growth slowing to 4% from 15% YoY, with adjusted EBITDAC margin down 30 bps to 30.9%. The company cited market challenges, including property pricing declines and increased competition. Management expects continued pressure in Q4 2026 and 2027, with modest margin expansion anticipated. They also discussed growth opportunities in reinsurance and AI-related risks, and potential M&A activity in 2027.

Med

Ryan Specialty grows revenue as property softening squeezes E&S returns

Ryan Specialty reported a 4.7% revenue increase to $790M in Q3 2026, driven by casualty lines, while property revenue declined. Underwriting management grew 5.4%, expanding its share of total revenue. Expenses rose 9.9%, outpacing revenue growth. The company maintained its full-year guidance for mid-single-digit organic revenue growth and reported a 3.8% increase in adjusted EBITDAC to $244.4M.